Mills Biopharmaceuticals Overview

  • Founded
  • 1992
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Mills Biopharmaceuticals General Information

Description

Provider of brachytherapy treatment services. The company is engaged in supplying of Iodine 125 and Palladium Pd-103 seeds for low dose prostate brachytherapy treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Core Oncology
Primary Office
  • 120 NorthEast 26th Street
  • Oklahoma City, OK 73105
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mills Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request a free trial

Mills Biopharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Stanley Mills Founder & President
To view Mills Biopharmaceuticals’s complete executive team members history, request access »

Mills Biopharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request a free trial